Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Nutt

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Journal of Movement Disorders|June 22, 2025
Variability in Pull Test Performance Within a Tertiary Movement Disorders CenterCarla Silva-Batista, Lee Neilson, Hanna Whang, et al.
Frontiers in Psychiatry|June 28, 2023
Psychedelic therapy in the treatment of addiction: the past, present and futureRayyan Zafar, Maxim Siegel, Rebecca Harding, et al.
Drug and Alcohol Dependence|May 23, 2017
The Standard Joint UnitCristina Casajuana Kögel, María Mercedes Balcells-Olivero, Hugo López-Pelayo, et al.
Journal of Psychopharmacology (Oxford, England)|August 4, 2022
Antidepressant effects of a psychedelic experience in a large prospective naturalistic sampleVictoria Amalie Nygart, Lis Marie Pommerencke, Eline Haijen, et al.
Annals of Neurology|December 26, 2006
Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patientsDenise M Kay, Dawn Moran, Lina Moses, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 2013
Effect of expectancy and personality on cortical excitability in Parkinson's diseaseJau-Shin Lou, Diana M Dimitrova, Richard Hammerschlag, et al.
Annals of Neurology|February 26, 2019
Magnetic resonance imaging-guided phase 1 trial of putaminal AADC gene therapy for Parkinson's diseaseChadwick W Christine, Krystof S Bankiewicz, Amber D Van Laar, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 3, 2003
SCA2 may present as levodopa-responsive parkinsonismHaydeh Payami, John Nutt, Steven Gancher, et al.
Archives of Neurology|February 16, 2006
A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuationsKaren Blindauer, Ira Shoulson, David Oakes, et al.
The Lancet. Neurology|December 21, 2007
Strategies to advance translational research into brain barriersEdward Neuwelt, N Joan Abbott, Lauren Abrey, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Movement Disorders|June 22, 2025
Variability in Pull Test Performance Within a Tertiary Movement Disorders CenterCarla Silva-Batista, Lee Neilson, Hanna Whang, et al.
Frontiers in Psychiatry|June 28, 2023
Psychedelic therapy in the treatment of addiction: the past, present and futureRayyan Zafar, Maxim Siegel, Rebecca Harding, et al.
Drug and Alcohol Dependence|May 23, 2017
The Standard Joint UnitCristina Casajuana Kögel, María Mercedes Balcells-Olivero, Hugo López-Pelayo, et al.
Journal of Psychopharmacology (Oxford, England)|August 4, 2022
Antidepressant effects of a psychedelic experience in a large prospective naturalistic sampleVictoria Amalie Nygart, Lis Marie Pommerencke, Eline Haijen, et al.
Annals of Neurology|December 26, 2006
Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patientsDenise M Kay, Dawn Moran, Lina Moses, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 2013
Effect of expectancy and personality on cortical excitability in Parkinson's diseaseJau-Shin Lou, Diana M Dimitrova, Richard Hammerschlag, et al.
Annals of Neurology|February 26, 2019
Magnetic resonance imaging-guided phase 1 trial of putaminal AADC gene therapy for Parkinson's diseaseChadwick W Christine, Krystof S Bankiewicz, Amber D Van Laar, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 3, 2003
SCA2 may present as levodopa-responsive parkinsonismHaydeh Payami, John Nutt, Steven Gancher, et al.
Archives of Neurology|February 16, 2006
A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuationsKaren Blindauer, Ira Shoulson, David Oakes, et al.
The Lancet. Neurology|December 21, 2007
Strategies to advance translational research into brain barriersEdward Neuwelt, N Joan Abbott, Lauren Abrey, et al.
Pageof 6